Header cover image
  • Investing Ideas
  • Norwegian Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Norwegian Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Results

1

0 new

Value score of at least 4 focused on companies with a low market cap.

1 companies

Navamedic

Market Cap: NOK 384.9m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

NAVA

NOK 16.05

7D

-2.4%

1Y

-37.1%